Current and Emerging Treatments for Myelodysplastic Syndromes: The 2021 Landscape

Current and Emerging Treatments for Myelodysplastic Syndromes: The 2021 Landscape
Current and Emerging Treatments for Myelodysplastic Syndromes: The 2021 Landscape
CME, CPE, CNE
Mikkael A. Sekeres, MD, MS, and Amy E. DeZern, MD, MHS
Release Date: October 25, 2021
Expiration Date: October 25, 2022

Historically, there have been few effective treatment options for MDS, creating a critical unmet need for therapies. New agents approved in 2020 represent the first new options for MDS in the last several years. Additional novel agents are on the horizon which hold promise to impact the current treatment paradigm.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Bristol-Myers Squibb and Astex Pharmaceuticals, Inc.

Begin, Earn CreditView Only, No Credit